By stimulating ATR–CHK1 signalling, activation of the G2/M and S/G2 cell-cycle checkpoints, at least in part, overcomes the lethal block caused by Brca1 deficiency through suppression of the mitotic catastrophe and promotes tumour initiation (Fig. 8g). This evidence concerns the gene ATR and neoplasm.